urea has been researched along with roflumilast in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aloliet, RI; Ansari, MN; Ganaie, MA; Hamad, AM; Imam, F; Khan, TH | 1 |
| Chudasama, P; Patel, P; Patel, S; Raval, M; Soni, S | 1 |
2 other study(ies) available for urea and roflumilast
| Article | Year |
|---|---|
Roflumilast, a phosphodiesterase 4 inhibitor, attenuates cadmium-induced renal toxicity via modulation of NF-κB activation and induction of NQO1 in rats.
Topics: Aminopyridines; Animals; Benzamides; Cadmium Chloride; Catalase; Creatinine; Cyclopropanes; Glutathione; Kidney; Kidney Diseases; Male; NAD(P)H Dehydrogenase (Quinone); NF-kappa B; Phosphodiesterase 4 Inhibitors; Rats, Wistar; Superoxide Dismutase; Urea | 2019 |
Roflumilast alleviates adenine-induced chronic kidney disease by regulating inflammatory biomarkers.
Topics: Adenine; Animals; Antioxidants; Biomarkers; Calcium; Creatinine; Kidney; Magnesium Chloride; Male; Rats; Rats, Wistar; Renal Insufficiency, Chronic; Transforming Growth Factor beta; Urea; Uric Acid | 2023 |